Information in clinical trials participants about the results;Información de los resultados a los participantes de los ensayos clínicos

Medicina Clinica

Volumn 128, Issue 10, 2007, Pages 375-378

  Dal Ré, Rafael ^a   Costa, Joan ^b  

^a GLAXOSMITHKLINE   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; HUMAN; MEDICAL INFORMATION; PATIENT RIGHT; PROGNOSIS; RESEARCH ETHICS; RESEARCH SUBJECT;

EID: 34247544395     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13099980     Document Type: Article

References (39)

1. National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects for research. Fed Regist. 1979;44:23192-7.
2. Gracia D. Fundamentos de bioética. Madrid: Eudema S.A.; 1989.
3. a. Asamblea General de la Asociación Médica Mundial. Edimburgo: Asociación Médica Mundial; 2000.
4. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH tripartite guideline for Good Clinical Practice. Geneva: ICH Secretariat; 1996.
5. Real Decreto 223/2004, de 6 de febrero, por el que se regulan los ensayos clínicos con medicamentos. BOE no. 33, de 7 de febrero de 2004.
6. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: CIOMS; 2002.
7. Dal-Ré R, Carne X. ¿Deben los pacientes recibir una remuneración económica por su participación en ensayos clinicos terapéuticos? Med Clin (Barc). 2006;127:59-65.
8. Herxheimer A. The rights of the patient in clinical research. Lancet. 1988;2:1128-30.
9. Goodare H, Smith R. The rights of patients in research. BMJ. 1995;310:1277-8.
10. Buchwald H, Fitch L, Matts JP, Johnson JW, Hansen BJ, Stuenkel MR, et al. Perception of quality of life before and after disclosure of trial results: a report from the program on the Surgical Control of the Hyperlipidemias (POSCH). Control Clin Trials. 1993;14:500-10.
11. Snowdown C, García J, Elbourne D. Reactions of participants to the results of a randomised controlled trial: exploratory study. BMJ. 1998;317: 21-6.
12. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council and Social Sciences and Humanities Research Council of Canada. TriCouncil Policy Statement. Ethical conduct for research involving humans. Ottawa; 1998 [con enmiendas en 2000, 2002, 2005].
13. nd ed. London: Department of Health; 2005 [consultado 17/08/2006]. Disponible en: www.dh.gov.uk/PublicationsAndStatistics/ Publications/PublicationsPolicyAndGuidedance/ PublicationsPolicyAndGuidedanceArticle/fs/en?CONTENT_ID=4108962&chk=Wde1Tv
14. General Medical Council. Research: the role and responsibilities of doctors. London: General Medical Council; 2002 [consultado 26/08/2006]. Disponible en: www.gmc-uk.org/guidance/library/research.asp
15. Trialists should tell participants results, but how? [editorial] Lancet. 2006;367:1030.
16. nd. ed. Baltimore: Urban & Schwarzenberg; 1986.
17. Partridge AH, Winer EP. Informing clinical trial participants about study results. JAMA. 2002;288:363-5.
18. Fernández CV, Kodish E, Weijer C. Informing study participants of research results: an ethical imperative. IRB Ethics Hum Res . 2003;25:12-9.
19. Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, et al. Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Nat Cancer Inst. 2004;96: 629-32.
20. Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Do patients participating in clinical trials want to know study results? J Nat Cancer Inst. 2003;95:491-2.
21. Fernández CV, Santor D, Weijer C, Strahlendorf C, Moghrabi A, Pentz R, et al. The return of research results to participants: pilot questionnaire of adolescents and parents of children with cancer. Pediatr Blood Cancer. 2006. DOI 10.1002/pbc.20766.
22. Schulz CJ, Riddle MP, Valdimirsdottir HB, Abramason DH, Sklar CA. Impact on survivors of retinoblastoma when informed of study results on risk of second cancers. Med Pediatr Oncol. 2003;41:36-43.
23. Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, et al. Offering participants results of a clinical trial: sharing results of a negative study. Lancet. 2005;365:963-4.
24. th European Breast cancer Conference, Nice, March 2006. Eur J Cancer. 2006;4 Suppl:84.
25. Dixon-Woods M, Jackson C, Windridge KC, Kenyon S. Receiving a summary of results of a trial: qualitative study of participants' views. BMJ. 2006;332:206-10.
26. Fernández CV, Kodish E, Shurin S, Weijer C. Offering to return results to research participants: attitudes and needs of principal investigators in the Children's Oncology Group. J Pediatr Hematol Oncol. 2003;25:704-8.
27. Rigby H, Fernández CV. Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting. Blood. 2005;106:1199-202.
28. Di Blasi Z, Kaptchuk TJ, Weiman J, Kleijnen J. Informing participants on allocation to placebo at trial closure: postal survey. BMJ. 2002;325:1329-31.
29. MacNeil DS, Fernández CV. Informing research participants of research results: analysis of Canadian university based research ethics boards policies. J Med Ethics. 2006;32:49-54.
30. Fernández CV, Kodish E, Taweel S, Shurin S, Weijer C. Disclosure of the right of research participants to receive research results. Cancer. 2003;97:2904-9.
31. Fernández CV, Skedgel C, Weijer C. Considerations and costs of disclosing study findings to research participants. CMAJ. 2004;170:1417-9.
32. Pitkin RM, Branagan MA, Burmeister LF. Accuracy of data in abstracts of published research articles. JAMA. 1999;281:1110-1.
33. Toma M, McAlister FA, Bialy L, Adams D, Vandermeer B, Armstrong PW. Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA. 2006;295:1281-7.
34. Fontanarosa PB, DeAngelis CD. The importance of the journal embargo. JAMA. 2002;288:748-50.
35. Kreza-Jeric K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C, for the Otawa Group. Principles for international registration of protocol information and results from human trials of health related interventions: Otawa statement (part 1). BMJ. 2005;330:956-9.
36. International Federation of Pharmaceutical Manufacturers & Associations. Postura conjunta sobre la revelación de información de ensayos clínicos mediante registros y bases de datos [consultado 26/08/2006]. Disponible: http://clinicaltrials-dev.ifpma.org/
37. Rockhold FW, Krall RL. Trials summaries on results databases and journal publication. Lancet. 2006;367:1365-6.
38. Ley 29/2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios. BOE no. 178, de 27 de julio de 2006.
39. Dinnett EM, Mungall MMB, Kent JA, Ronala ES, McIntyre KE, Anderson E, et al. Unblinding of trial participants to their treatment allocation: lessons from the prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Clin Trials. 2005;2:254-9.